20.1 C
New York
Monday, June 8, 2026

Tag: chart

Boise to welcome up to 50,000 for Basque festival

BOISE, Idaho, July 24, 2025 /PRNewswire/ -- Every five years, Idaho's state capital becomes the Basque capital of America as up to 50,000 of...

Crown Castle Reports Second Quarter 2025 Results and Increases Outlook For Full Year 2025

HOUSTON, July 23, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today reported results for the second quarter ended June 30, 2025 and updated its full year 2025 Outlook, as reflected in the table below.

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

Record revenue of $1.7 billion, up 10% from Q2 2024Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024CHICAGO, July...

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

Bad Credit Loan Providers with Guaranteed Approval & No Credit Check: Why MoneyMutual Is the Last One Standing in 2025

In this 2025 report on the best bad credit loan providers with guaranteed approval and no credit check required, we examine how MoneyMutual stands out in a shrinking industry. As other platforms disappear or get flagged for compliance violations, MoneyMutual continues to connect borrowers with fast $500 loans, emergency cash advances, and secure same-day lending access—even for people with low or no credit scores.
In this 2025 report on the best bad credit loan providers with guaranteed approval and no credit check required, we examine how MoneyMutual stands out in a shrinking industry. As other platforms disappear or get flagged for compliance violations, MoneyMutual continues to connect borrowers with fast $500 loans, emergency cash advances, and secure same-day lending access—even for people with low or no credit scores.

Italian American Legend Connie Francis Belongs in the Rock & Roll Hall of Fame

The Conference of Presidents of Major Italian American Organizations (COPOMIAO) launches advocacy campaign on behalf of Francis, whose chart-topping ballads once ruled the airwaves...

VINEYARD VINES PARTNERS WITH ZAC BROWN BAND WITH AN EXCLUSIVE, LIMITED-EDITION CAPSULE COLLECTION

STAMFORD, Conn., July 18, 2025 /PRNewswire/ -- vineyard vines, the iconic lifestyle brand known for its smiling pink whale logo and "Every Day Should...

FOR KING + COUNTRY RETURNS WITH FAN-FAVORITE CHRISTMAS EVENT, ‘A DRUMMER BOY CHRISTMAS: THE LIVE EXPERIENCE,’ IN SELECT CITIES THIS DECEMBER

An up-close and unforgettable Christmas tradition — the only chance to see the band live in 2025 NASHVILLE, Tenn., July 16, 2025 /PRNewswire/ -- Four-time GRAMMY®...

An Unprecedented Look at What Made Taylor Swift a Global Phenomenon: Her Music

Taylor Swift: Album by AlbumBy Kase Wickman, Joanna Weiss, Moira McAvoy ∙ October 7, 2025 MINNEAPOLIS, July 16, 2025 /PRNewswire/ -- Taylor Swift is a global...

Two in five Pre-Retirees Say Dreams for Retirement Have Been Delayed, Altered or Cancelled

Pre-Retirees Abandon Traditional Retirement Planning Rules of Thumb as Economy Forces an Investment Playbook Rewrite COLUMBUS, Ohio, July 15, 2025 /PRNewswire/ -- Pre-retiree investors (aged...

Topflight Pharma Development Veteran Joins Synendos

Dr. George Garibaldi is named Chief Medical Officer as Synendos transitions from Phase 1 into Phase 2 of its clinical development strategy.

Study examines safety, cost, and environmental tradeoffs of re-using versus discarding medical devices

ECRI assessed evidence surrounding single-use vs. reprocessed medical devices in hospitals WILLOW GROVE, Pa., July 14, 2025 /PRNewswire/ -- One way healthcare providers attempt to reduce...

Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa

First modules of BLA submitted to FDA under rolling review, with full submission anticipated in early 2026MCO-010 BLA for retinitis pigmentosa is eligible for priority review...

FIRST ROUND OF PERFORMERS UNVEILED FOR THE 2025 CCMA AWARDS PRESENTED BY TD

MADELINE MERLO & TYLER JOE MILLER, SACHA & RESTLESS ROAD, DALLAS SMITH & ALEXANDRA KAY, THELMA & JAMES, AND CAMERON WHITCOMB WILL TAKE THE STAGE AT...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsChart